Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway

No abstract is available for this paper.

• Publication year

  2001

• Venue

  FEBS Letters

• Publication date

  2001-07-27

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-5793(01)02651-5PMID 11478941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphorylation of the Protein Kinase Mutated in Peutz-Jeghers Cancer Syndrome, LKB1/STK11, at Ser431 by p90RSK and cAMP-dependent Protein Kinase, but Not Its Farnesylation at Cys433, Is Essential for LKB1 to Suppress Cell Growth*

  2001cited by this paper
• ERK5 and ERK2 Cooperate to Regulate NF-κB and Cell Transformation*

  2001cited by this paper
• ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation.

  2001cited by this paper
• MEKK2 Associates with the Adapter Protein Lad/RIBP and Regulates the MEK5-BMK1/ERK5 Pathway*

  2001cited by this paper
• Specificity and mechanism of action of some commonly used protein kinase inhibitors.

  2000cited by this paper
• Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.

  2000cited by this paper
• Specificity and mechanism of action of some commonly used protein kinase inhibitors

  2000cited by this paper
• Activation of the Protein Kinase ERK5/BMK1 by Receptor Tyrosine Kinases

  1999cited by this paper
• MEKK3 Directly Regulates MEK5 Activity as Part of the Big Mitogen-activated Protein Kinase 1 (BMK1) Signaling Pathway*

  1999cited by this paper
• Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

  1999cited by this paper
• Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor

  1998cited by this paper
• Exchange of Aspartate and Alanine

  1996cited by this paper
• Big Mitogen-activated Protein Kinase 1 (BMK1) Is a Redox-sensitive Kinase*

  1996cited by this paper
• A synthetic inhibitor of the mitogen-activated protein kinase cascade.

  1995cited by this paper
• Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf.

  1995cited by this paper
• Isolation of MEK5 and Differential Expression of Alternatively Spliced Forms *

  1995cited by this paper
• PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*)

  1995cited by this paper
• Components of a New Human Protein Kinase Signal Transduction Pathway (*)

  1995cited by this paper
• Identification of the sites in MAP kinase kinase‐1 phosphorylated by p74raf‐1.

  1994cited by this paper
• Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase

  1990cited by this paper

• PIEZO1 Overexpression in Hereditary Hemorrhagic Telangiectasia Arteriovenous Malformations.

  2025cites this paper
• Gastrodin ameliorates acute pancreatitis by modulating macrophage inflammation cascade via inhibition the p38/NF-κB pathway.

  2024cites this paper
• A stepwise and digital pattern of RSK phosphorylation determines the outcome of thymic selection

  2023cites this paper
• Novel trajectories of the NK1R antagonist aprepitant in rotenone-induced Parkinsonism-like symptoms in rats: Involvement of ERK5/KLF4/p62/Nrf2 signaling axis.

  2023cites this paper
• Identification of mitogen‐activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies

  2023cites this paper
• VEGF Stimulates Activation of ERK5 in the Absence of C-Terminal Phosphorylation Preventing Nuclear Localization and Facilitating AKT Activation in Endothelial Cells

  2023cites this paper
• The role of MEK1/2 and MEK5 in melatonin‐mediated actions on osteoblastogenesis, osteoclastogenesis, bone microarchitecture, biomechanics, and bone formation

  2022cites this paper
• Protocadherin 15 suppresses oligodendrocyte progenitor cell proliferation and promotes motility through distinct signalling pathways

  2022cites this paper
• Hemin-Induced Death Models Hemorrhagic Stroke and Is a Variant of Classical Neuronal Ferroptosis

  2022cites this paper
• Title: p38δ Regulates IL6 Expression Modulating ERK Phosphorylation in Preadipocytes

  2022influential citation
• The MAP kinase ERK5/MAPK7 is a downstream effector of oxytocin signaling in myometrial cells.

  2021cites this paper
• Extracellular signal‐regulated kinases 2 (Erk2) and Erk5 in the central nervous system differentially contribute to central sensitization in male mice

  2021cites this paper
• A Redox-Sensitive Thiol in Wis1 Modulates the Fission Yeast Mitogen-Activated Protein Kinase Response to H₂O₂ and Is the Target of a Small Molecule

  2020cites this paper
• A Redox-Sensitive Thiol in Wis1 Modulates the Fission Yeast Mitogen-Activated Protein Kinase Response to H2O2 and Is the Target of a Small Molecule

  2020cites this paper
• Platelet MAPKs—a 20+ year history: What do we really know?

  2020cites this paper
• Targeted Avenues for Cancer Treatment: The MEK5-ERK5 Signaling Pathway.

  2020cites this paper
• Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy

  2020cites this paper
• Involvement of p38 MAPK in Synaptic Function and Dysfunction

  2020cites this paper
• A redox-sensitive thiol in Wis1 modulates the fission yeast MAPK response to H2O2 and is the target of a small molecule

  2020cites this paper
• iPSC-Derived Cardiomyocytes Reveal Aberrant ERK5 and MEK1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome.

  2019cites this paper
• Preclinical effects of highly potent MEK1/2 inhibitors on rat cerebral vasculature after organ culture and subarachnoid haemorrhage.

  2019cites this paper
• Asymmetric dimethylarginine: An crucial regulator in tissue fibrosis.

  2019cites this paper
• Inhibition of MEK5 suppresses TDP-43 toxicity via the mTOR-independent activation of the autophagy-lysosome pathway.

  2019cites this paper
• Roles of extra-cellular signal-regulated protein kinase 5 signaling pathway in the development of spinal cord injury

  2019cites this paper
• Up-regulation of DcR3 in microbial toxins-stimulated HUVECs involves NF-κB signalling

  2018cites this paper
• Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology

  2018cites this paper
• Role of Mitogen Activated Protein Kinase Signaling in Parkinson’s Disease

  2018cites this paper
• A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC

  2018cites this paper
• Nous mecanismes implicats en els dèficits transcripcionals i la pèrdua del bdnf en la malaltia de huntington: descripció de noves dianes terapèutiques

  2018cites this paper
• Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion

  2018cites this paper
• The Oxytocin Receptor: From Intracellular Signaling to Behavior.

  2018cites this paper
• Computer simulation of a large-scale signalling network regulating translation Initiation in the mammalian cell.

  2017cites this paper
• TSC2/Rheb signaling mediates ERK‐dependent regulation of mTORC1 activity in C2C12 myoblasts

  2017cites this paper
• DNA damage induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes β-catenin-mediated invasion.

  2016cites this paper
• Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration*

  2016cites this paper
• ERK5 and Cell Proliferation: Nuclear Localization Is What Matters

  2016cites this paper
• Distinct intracellular signaling mediates C‐MET regulation of dendritic growth and synaptogenesis

  2016cites this paper
• ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation

  2016cites this paper
• Regulation of prostate cancer cell function by activators of AMP-activated protein kinase

  2016cites this paper
• Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation

  2016influential citation
• MEK5 suppresses osteoblastic differentiation.

  2015cites this paper
• Vascular endothelial cell Toll-like receptor pathways in sepsis

  2015cites this paper
• Role of the ERK1/2 pathway in tumor chemoresistance and tumor therapy.

  2015cites this paper
• Coxsackievirus B3 replication and pathogenesis.

  2015cites this paper
• The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage.

  2015cites this paper
• Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability.

  2015cites this paper
• Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?

  2015cites this paper
• Mechanism of interferon-gamma production by monocytes stimulated with myeloperoxidase and neutrophil extracellular traps.

  2015cites this paper
• The Implication of Cancer Progenitor Cells and the Role of Epigenetics in the Development of Novel Therapeutic Strategies for Chronic Myeloid Leukemia

  2015cites this paper
• Proteins in the ERK pathway are affected by arsenic-treated cells

  2015cites this paper
• MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road

  2015cites this paper
• ERK reinforces actin polymerization to power persistent edge protrusion during motility

  2015cites this paper
• p38 mitogen-activated protein kinase and transcription factor GATA-4 in the regulation of cardiomyocyte function

  2014cites this paper
• Modulation of Clr-b Ligand for the Inhibitory NKR-P1B NK Cell Receptor in Response to Transformation and Genotoxic Stress

  2014cites this paper
• Role of ERK1, 2, and 5 in dopamine neuron survival during aging.

  2014influential citation
• A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis.

  2014cites this paper
• Differential Roles of CXCL2 and CXCL3 and Their Receptors in Regulating Normal and Asthmatic Airway Smooth Muscle Cell Migration

  2013cites this paper
• Programmed Cell Death in T Cell Development

  2013cites this paper
• RAS–MAPK–MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1

  2013cites this paper
• This information is current as Migration Asthmatic Airway Smooth Muscle Cell Their Receptors in Regulating Normal and Differential Roles of CXCL 2 and CXCL 3 and

  2013cites this paper
• Part I: Catalytic Direct C-H Arylation of Pyrazoles Part II: Toward Modulation of Neuroplasticity with Small Molecules

  2013cites this paper
• MAPK signalling : ERK 5 versus ERK 1 / 2

  2013cites this paper
• MEK Inhibitor U0126 Reverses Protection of Axons from Wallerian Degeneration Independently of MEK–ERK Signaling

  2013influential citation
• PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.

  2013cites this paper
• The Role of ERK5 in Cell Proliferation

  2013cites this paper
• Supporting cells and ERK signalling: determining their roles in hair cell death

  2013cites this paper
• The role of Extracellular-Regulated Protein Kinase 2 (ERK2) in cardiac hypertrophic remodelling

  2013cites this paper
• Stimuli That Activate MSK in Cells and the Molecular Mechanism of Activation

  2013cites this paper
• Effects of the phosphatase SHP2 in breast cancer and metastasis

  2013cites this paper
• Extracellular regulated kinase5 is expressed in fetal mouse submandibular glands and is phosphorylated in response to epidermal growth factor and other ligands of the ErbB family of receptors

  2012cites this paper
• Mechanical allodynia but not thermal hyperalgesia is impaired in mice deficient for ERK2 in the central nervous system

  2012cites this paper
• Extracellular signal‐regulated kinase 1/2 signaling promotes oligodendrocyte myelination in vitro

  2012cites this paper
• ERK5 Protein Promotes, whereas MEK1 Protein Differentially Regulates, the Toll-like Receptor 2 Protein-dependent Activation of Human Endothelial Cells and Monocytes*

  2012cites this paper
• The PP242 Mammalian Target of Rapamycin (mTOR) Inhibitor Activates Extracellular Signal-regulated Kinase (ERK) in Multiple Myeloma Cells via a Target of Rapamycin Complex 1 (TORC1)/ Eukaryotic Translation Initiation Factor 4E (eIF-4E)/RAF Pathway and Activation Is a Mechanism of Resistance*

  2012cites this paper
• Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop

  2012cites this paper
• MEK5/ERK5 pathway: the first fifteen years.

  2012influential citation
• 3D‐QSAR and Molecular Docking Studies on Substituted Isothiazole Analogs as Inhibitors Against MEK‐1 Kinase

  2012cites this paper
• MEK/Erk-based negative feedback mechanism involved in control of Steel Factor-triggered production of Krüppel-like factor 2 in mast cells.

  2012cites this paper
• Identification of microRNAs that mediate thyroid cell growth induced by TSH.

  2012cites this paper
• Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17

  2012cites this paper
• Stimuli That Activate MSK in Cells and the Molecular Mechanism

  2012cites this paper
• ERK5 signalling in prostate cancer promotes an invasive phenotype

  2011cites this paper
• Tyrosine Phosphatases in the HER2-Directed Motility of Ovarian Cancer Cells: Involvement of PTPN12, ERK5 and FAK

  2011influential citation
• Molecular Pathways Targeting the BMK 1 MAP Kinase Pathway in Cancer Therapy

  2011cites this paper
• Targeting the BMK1 MAP Kinase Pathway in Cancer Therapy

  2011cites this paper
• ERK5 regulates muscle cell fusion through Klf transcription factors.

  2011cites this paper
• Met Receptors Induce Sam68-dependent Cell Migration by Activation of Alternate Extracellular Signal-regulated Kinase Family Members*

  2011cites this paper
• Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases

  2011influential citation
• Intracellular signaling networks regulate host-cell responses to coxsackievirus B3 infection

  2011cites this paper
• MEK5/ERK5/mef2: a novel signaling pathway affected by hepatitis C virus non-enveloped capsid-like particles.

  2011influential citation
• Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation.

  2011cites this paper
• Activation of the spinal extracellular signal-regulated kinase 5 signaling pathway contributes to morphine physical dependence in rats.

  2011cites this paper
• Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells

  2010cites this paper
• Regulation of breast tumor Kinase (Brk/PTK6) downstream of Met receptor signaling leads to breast cancer cell migration.

  2010cites this paper
• Raf-1 Activation Prevents Caspase 9 Processing Downstream of Apoptosome Formation

  2010cites this paper
• Mechanisms of FSH synthesis: what we know, what we don't, and why you should care.

  2010cites this paper
• The ERK5 and ERK1/2 signaling pathways play opposing regulatory roles during chondrogenesis of adult human bone marrow‐derived multipotent progenitor cells

  2010cites this paper
• Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.

  2010cites this paper
• PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.

  2010cites this paper
• Mini-review: CNS Melatonin Receptors and Signaling: Focus on Aging-Related Diseases and Future Perspectives

  2010influential citation